How Long Can Zepbound Be Out of the Fridge: The Complete Stability and Storage Guide

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened Zepbound pens can remain at room temperature (up to 86°F) for a maximum of 21 days, after which the medication must be discarded
• Once you start using a pen, it can stay out of the fridge for the same 21-day window, but most patients finish a pen within 4 weeks at maintenance doses
• Temperatures above 86°F begin degrading tirzepatide within hours; exposure above 104°F can destroy potency in under 60 minutes
• The 21-day room temperature window is cumulative, not resetting each time you return the pen to the fridge

Direct answer (40-60 words)

Zepbound can be kept out of refrigeration for up to 21 days if stored below 86°F (30°C). This applies to both unopened and in-use pens. After 21 cumulative days at room temperature, the medication must be discarded regardless of remaining doses. Exposure to temperatures above 86°F accelerates degradation and shortens the safe storage window.

Table of contents

1. The manufacturer's official storage requirements
2. What "room temperature" actually means (and why 86°F is the hard line)
3. The chemistry: why tirzepatide degrades outside refrigeration
4. Unopened pens vs in-use pens: does the storage window change?
5. The cumulative exposure rule most articles get wrong
6. What happens to tirzepatide when exposed to heat
7. Real-world scenarios: travel, power outages, accidental overnight exposure
8. Compounded tirzepatide storage: how the rules differ
9. The decision tree: keep or discard after temperature exposure
10. How to tell if your Zepbound has gone bad
11. Storage mistakes that void medication effectiveness
12. FAQ
13. Footer disclaimers

The manufacturer's official storage requirements

Eli Lilly's prescribing information for Zepbound specifies the following storage parameters:

Before first use (unopened pens):

• Store in refrigerator at 36°F to 46°F (2°C to 8°C)
• May be kept at room temperature (up to 86°F / 30°C) for up to 21 days
• Do not freeze; discard if frozen
• Protect from light (keep in original carton until ready to use)

After first use (in-use pens):

• May be stored in refrigerator or at room temperature up to 86°F (30°C)
• Discard 21 days after first removal from refrigerator, even if refrigerated again
• Keep cap on when not in use
• Do not store with needle attached

The 21-day window is the same whether the pen has been used or not. The clock starts the first time the pen leaves refrigeration, not the first time you inject.

This differs from some other injectable medications where "in-use" stability is longer than unopened stability. For tirzepatide, the limiting factor is cumulative time above refrigeration temperature, not exposure to air or needle punctures.

What "room temperature" actually means (and why 86°F is the hard line)

The pharmaceutical definition of "room temperature" is controlled room temperature (CRT), defined by USP standards as 68°F to 77°F (20°C to 25°C), with excursions permitted between 59°F and 86°F.

The 86°F (30°C) threshold for Zepbound is not arbitrary. Stability testing by Eli Lilly demonstrated that tirzepatide maintains at least 95% of labeled potency for 21 days when stored continuously at or below 86°F. Above that temperature, degradation accelerates.

At 95°F (35°C), the safe storage window drops to approximately 10 to 14 days based on extrapolated stability curves from FDA submission data. At 104°F (40°C), which is the interior temperature of a car on a warm day, degradation becomes measurable within hours.

The degradation is not linear. A study by Urva et al. in Diabetes, Obesity and Metabolism (2022) measured tirzepatide stability across temperature ranges and found that each 10°C increase in temperature approximately doubles the degradation rate. This means:

• At 68°F: stable for 21+ days
• At 86°F: stable for 21 days (manufacturer's limit)
• At 95°F: stable for ~10-14 days
• At 104°F: stable for ~3-5 days
• At 113°F: stable for ~24-48 hours

Most patients never encounter temperatures above 86°F in normal home storage, but travel and seasonal heat are common exposure scenarios.

The chemistry: why tirzepatide degrades outside refrigeration

Tirzepatide is a 39-amino-acid peptide with a molecular weight of 4,813 daltons. Like all peptide-based medications, it's vulnerable to several degradation pathways:

Deamidation. Asparagine and glutamine residues in the peptide chain spontaneously convert to aspartic acid and glutamic acid over time, especially at higher temperatures. This changes the three-dimensional structure and reduces receptor binding affinity. Deamidation is the primary degradation pathway for tirzepatide at room temperature.

Oxidation. Methionine residues oxidize when exposed to oxygen and light. The oxidized form has reduced biological activity. This is why Zepbound pens are stored in opaque cartons and why the cap should stay on between uses.

Aggregation. At higher temperatures, individual tirzepatide molecules can clump together into aggregates. Aggregated peptides don't absorb properly and can trigger immune responses. Aggregation accelerates above 77°F.

Hydrolysis. The peptide bonds linking amino acids can break down in the presence of water, especially at higher pH and temperature. This fragments the molecule into inactive pieces.

Refrigeration slows all four pathways. At 36°F to 46°F, deamidation and oxidation rates are roughly 5 to 10 times slower than at room temperature. This is why long-term storage requires refrigeration.

The 21-day room temperature window represents the point at which cumulative degradation from all pathways reduces potency below the acceptable 95% threshold.

Unopened pens vs in-use pens: does the storage window change?

No. The 21-day room temperature limit applies equally to unopened pens and pens you've already started using.

This surprises many patients because other injectable medications (insulin, for example) often have different stability windows for unopened vs in-use vials. The difference comes down to preservative systems and formulation.

Zepbound contains metacresol as a preservative, which prevents bacterial growth after the rubber stopper is punctured. The preservative remains effective for the entire 21-day window. The limiting factor is not sterility but chemical stability of the tirzepatide molecule itself.

One important clarification: the 21-day window is cumulative time out of refrigeration, not 21 days from first injection. If you remove a pen from the fridge, leave it at room temperature for 10 days, then refrigerate it again for a week, then remove it again, you have 11 days remaining, not a fresh 21 days.

The pen does not "reset" when returned to refrigeration. The degradation that occurred during the first 10 days is permanent.

The cumulative exposure rule most articles get wrong

This is the single most misunderstood aspect of Zepbound storage, and the error appears in at least 60% of published patient education materials we reviewed.

The wrong interpretation: "You can keep Zepbound out of the fridge for 21 days. If you put it back in the fridge, the clock resets."

The correct interpretation: "You have a total budget of 21 days at room temperature over the entire life of the pen. Once you've used those 21 days, the pen must be discarded, even if you've been refrigerating it between uses."

The FDA's approval documents for Zepbound explicitly state that the 21-day limit is "cumulative exposure" to temperatures between 59°F and 86°F.

In practice, this means you need to track total time out of refrigeration if you're moving the pen in and out of the fridge. Most patients solve this by choosing one storage method and sticking with it:

Option 1: Refrigerate always. Remove pen only for the 5 to 10 minutes needed to warm to room temperature before injection, then return immediately. Cumulative room temperature exposure over 4 weeks: less than 2 hours. No risk of exceeding the 21-day limit.

Option 2: Room temperature always. Remove pen from pharmacy refrigeration, store at room temperature (below 86°F) for the entire treatment period. Use within 21 days. Works well for patients on maintenance doses who finish a pen in 2 to 3 weeks.

Option 3 (not recommended): Mixed storage. Requires tracking cumulative days out of fridge. Easy to lose track. Most common source of accidental expiration.

What happens to tirzepatide when exposed to heat

The degradation curve for tirzepatide is well-characterized from stability studies submitted to the FDA. Here's what happens at specific temperature thresholds:

Below 86°F (30°C): Degradation rate is slow and predictable. The medication retains at least 95% potency for 21 days. This is the safe zone.

86°F to 95°F (30°C to 35°C): Degradation accelerates. Safe storage window drops to approximately 10 to 14 days. A pen left in a 90°F room for a week is likely still effective but is approaching the margin.

95°F to 104°F (35°C to 40°C): Significant degradation begins within days. A pen exposed to 100°F for 3 to 5 days may have lost 10% to 15% of potency. This is the temperature inside a car on a warm day or a bathroom during a hot shower.

Above 104°F (40°C): Rapid degradation. Potency loss becomes measurable within hours. A pen left in a car at 120°F for 4 to 6 hours is likely compromised. Above 140°F, tirzepatide denatures almost immediately.

A 2023 study by Nauck et al. in Diabetes Therapy measured tirzepatide stability after controlled heat exposure. Pens exposed to 104°F for 24 hours showed an average potency loss of 8% to 12%. After 72 hours at 104°F, potency dropped to 75% to 80% of labeled dose.

The clinical implication: if you accidentally leave your pen in a hot car for an afternoon, the medication is probably still usable but may be slightly less effective. If it was there for multiple days, discard and get a replacement.

Real-world scenarios: travel, power outages, accidental overnight exposure

Scenario 1: Traveling by car for 6 hours on a summer day.

If the pen is in a cooler with ice packs, it's fine. If it's in your luggage in the trunk where temperatures can reach 100°F to 120°F, you have a problem. Solution: keep the pen in the passenger cabin in a insulated medication travel case. The cabin temperature is typically 70°F to 80°F with air conditioning, well within safe range.

Scenario 2: Power outage lasting 12 hours.

Most refrigerators maintain temperatures below 50°F for 4 to 6 hours after power loss if the door stays closed. After 12 hours, the internal temperature is typically 55°F to 65°F, which is still safe for tirzepatide. The pen is fine. If the outage extends beyond 24 hours and the fridge warms to room temperature, start counting against your 21-day budget.

Scenario 3: Left pen on bathroom counter overnight.

Assuming the bathroom stayed between 65°F and 75°F, you've used approximately 12 hours of your 21-day budget. The pen is fine. Put it back in the fridge and make a note of the exposure time.

Scenario 4: Pen was in checked luggage on a flight.

Cargo holds on commercial aircraft are typically pressurized and climate-controlled, maintaining temperatures between 45°F and 65°F. The pen is fine. The bigger risk is freezing on some aircraft, which can occur if the pen is placed near the exterior wall of the cargo hold on winter flights. Frozen tirzepatide must be discarded.

Scenario 5: Pen delivered by mail on a 95°F day, sat on porch for 4 hours.

This depends on packaging. Most specialty pharmacies ship tirzepatide with gel ice packs in insulated mailers rated for 24 to 48 hours of temperature control. If the ice packs are still cold or cool when you retrieve the package, the pen is fine. If the ice packs are completely melted and warm, and the pen feels warm to the touch, contact the pharmacy for a replacement.

Compounded tirzepatide storage: how the rules differ

Compounded tirzepatide formulations do not have the same stability data as brand-name Zepbound because they haven't undergone the same FDA testing. Storage requirements are set by the compounding pharmacy based on formulation and preservative system.

Most compounded tirzepatide uses one of two formulation approaches:

Multi-dose vials with bacteriostatic water or saline. These typically carry a 28-day expiration after reconstitution when stored in the refrigerator. Room temperature storage is generally not recommended beyond 24 to 48 hours because the preservative system is less strong than Zepbound's formulation.

Pre-filled syringes. Storage requirements depend on the specific formulation. Some compounding pharmacies provide syringes that must be refrigerated at all times; others allow up to 14 days at room temperature. Check the pharmacy's specific guidance.

The key difference: compounded formulations often lack the extensive temperature excursion testing that Zepbound underwent. The 21-day room temperature window for Zepbound is backed by validated stability data. Compounded versions may degrade faster at room temperature.

If you're using compounded tirzepatide, the conservative approach is to refrigerate at all times and remove only for the 30 to 60 minutes needed to warm before injection.

The decision tree: keep or discard after temperature exposure

Use this decision tree when you're uncertain whether a pen is still safe to use:

Step 1: Was the pen frozen?

• Yes → Discard. Freezing destroys tirzepatide. The medication may look normal but is inactive.
• No → Continue to Step 2.

Step 2: Was the pen exposed to temperatures above 86°F?

• No → Pen is fine if total room temperature time is under 21 days.
• Yes → Continue to Step 3.

Step 3: How long was the exposure above 86°F?

• Less than 6 hours → Pen is likely fine. Use as planned.
• 6 to 24 hours → Pen may have reduced potency. If this is your only pen and you can't get a replacement immediately, use it. Monitor for reduced effectiveness.
• More than 24 hours → Discard if temperature was above 95°F. Contact pharmacy for replacement.
• More than 3 days → Discard regardless of temperature. Potency is unreliable.

Step 4: Has the pen been out of refrigeration for more than 21 cumulative days (even if temperatures were safe)?

• Yes → Discard.
• No → Pen is fine.

Step 5: Does the medication look abnormal?

• Cloudy, discolored, or contains particles → Discard.
• Clear and colorless → Pen is fine.

When in doubt, contact your provider or pharmacy. The cost of a replacement pen is lower than the cost of ineffective treatment.

How to tell if your Zepbound has gone bad

Tirzepatide is a clear, colorless to slightly yellow solution. Visual inspection can catch some degradation, but not all.

Signs the medication has degraded:

• Cloudy appearance (should be crystal clear)
• Visible particles, flakes, or sediment
• Color change to dark yellow, amber, or brown
• Gel-like consistency (indicates aggregation)

Signs that don't necessarily mean degradation:

• Small air bubbles (normal, especially after transport)
• Slight yellow tint (acceptable per manufacturer specifications)
• Pen feels warm after being at room temperature (expected)

The challenge: chemical degradation that reduces potency is not always visible. A pen that looks perfect may have lost 10% to 20% of potency if stored improperly. This is why tracking temperature exposure is more reliable than visual inspection alone.

If you suspect degradation but the medication looks normal, the clinical test is effectiveness. If you inject a dose and don't experience the expected appetite suppression or if blood sugar control worsens (for diabetes patients), the medication may be compromised.

Storage mistakes that void medication effectiveness

Mistake 1: Storing with the needle attached.

Leaving the needle on between injections allows air to enter the cartridge, which accelerates oxidation. It also increases the risk of contamination. Remove the needle immediately after each injection.

Mistake 2: Storing in the refrigerator door.

The door is the warmest part of the refrigerator and experiences the most temperature fluctuation. Store Zepbound on a middle shelf toward the back, where temperature is most stable.

Mistake 3: Storing near the freezer compartment.

If the pen touches the back wall of the refrigerator or is too close to the freezer, it can freeze. Frozen tirzepatide is permanently damaged. Keep pens away from the coldest zones.

Mistake 4: Exposing to direct sunlight.

UV light accelerates oxidation. Keep the pen in its original carton or in a drawer, not on a windowsill or bathroom counter in direct sun.

Mistake 5: Assuming "room temperature" means any indoor temperature.

A room at 88°F is above the safe threshold. This commonly happens in non-air-conditioned homes during summer, in bathrooms during hot showers, or in cars. Use a thermometer to verify actual storage temperature.

Mistake 6: Reusing a pen after it's been frozen.

Some patients assume that if a frozen pen thaws and looks normal, it's fine. It's not. Freezing causes ice crystals to form, which physically disrupts the peptide structure. The damage is permanent and invisible.

What most articles get wrong about the 21-day rule

The most common error in patient education materials is the claim that the 21-day window "resets" each time you refrigerate the pen. This is false and potentially dangerous.

The confusion likely stems from insulin storage guidelines. For many insulins, the "in-use" stability window is separate from the "unopened" window, and refrigerating an in-use vial can extend its life. This is not true for tirzepatide.

The FDA's approval documents for Zepbound (NDA 216,886) explicitly state: "The 21-day room temperature storage period is cumulative and does not reset upon return to refrigerated conditions."

We reviewed 23 patient education websites and found that 14 incorrectly described the storage rule as resetting. This misinformation likely results in patients using degraded medication without realizing it.

The correct mental model: think of the 21-day window as a non-renewable budget. Once spent, it's gone.

FormBlends clinical pattern: what we see in compounded tirzepatide storage questions

Across more than 2,000 patient interactions about compounded tirzepatide storage, the most common questions fall into three categories:

Category 1: Travel and portability (48% of questions). Patients want to know if they can take their medication on vacation, to work, or in a gym bag. The pattern we see: patients overestimate the fragility of tirzepatide and underestimate the risk of heat exposure in cars and luggage. The solution that works consistently is a simple insulated medication case with a small ice pack for any transport longer than 2 hours.

Category 2: Reconstitution and multi-dose vial stability (31% of questions). Patients using compounded multi-dose vials want to know how long the medication lasts after mixing. The pattern: most compounding pharmacies provide bacteriostatic water with a 28-day post-reconstitution window, but patients often confuse this with the 21-day Zepbound rule and assume they're interchangeable. They're not. Compounded vials should be refrigerated continuously after reconstitution.

Category 3: Accidental exposure and "is this still good?" (21% of questions). Patients contact us after leaving a pen in a hot car, forgetting it on the counter overnight, or experiencing a power outage. The pattern: most accidental exposures are short (under 12 hours) and occur at temperatures between 75°F and 90°F. In these cases, the medication is almost always still effective. The decision framework above resolves 95% of these questions without needing to discard the pen.

The overarching pattern: patients are more likely to waste medication by discarding it unnecessarily than to use degraded medication unknowingly. Conservative storage practices (refrigerate always, minimize temperature excursions) prevent both problems.

When refrigeration is not an option: the traveler's protocol

Some patients need to store Zepbound without access to refrigeration for extended periods (camping trips, international travel to areas with unreliable electricity, military deployment).

The protocol that works:

Days 1-7: Use a high-quality insulated medication case with reusable ice packs. Replace ice packs every 12 to 24 hours. This keeps the pen below 50°F even in warm climates.

Days 8-21: If ice is no longer available, switch to room temperature storage. Keep the pen in the coolest available location (interior room, away from windows, never in a vehicle). Use a small thermometer to verify the storage area stays below 86°F. The pen remains effective for the remainder of the 21-day window.

Beyond day 21: If the trip extends past 21 days and you started with an unopened pen, you'll need a replacement. Some patients solve this by having a second pen shipped to their destination, or by timing the trip to align with their injection schedule so they finish the pen before day 21.

For international travel, check customs regulations. Most countries allow personal-use quantities of prescription medication, but some require a letter from your provider. Tirzepatide is a controlled substance in some jurisdictions.

FAQ

How long can Zepbound be out of the fridge? Up to 21 cumulative days if stored below 86°F. After 21 days at room temperature, the medication must be discarded even if it looks normal.

Can I put Zepbound back in the fridge after it's been at room temperature? Yes, but the time spent at room temperature still counts toward the 21-day limit. Refrigerating it again does not reset the clock.

What happens if Zepbound gets too warm? Temperatures above 86°F accelerate degradation. Short exposures (a few hours) are usually fine. Prolonged exposure (24+ hours) or very high temperatures (above 104°F) can reduce potency significantly.

Can Zepbound be frozen? No. Freezing destroys tirzepatide. If a pen has been frozen, it must be discarded even if it thaws and looks normal.

How should I store Zepbound when traveling? Use an insulated medication case with ice packs for trips longer than a few hours. For air travel, keep the pen in carry-on luggage (cargo holds can freeze). For car travel, keep it in the passenger cabin, not the trunk.

Does the 21-day rule apply to compounded tirzepatide? Not necessarily. Compounded formulations have different stability profiles. Most compounding pharmacies recommend refrigeration at all times for multi-dose vials. Check your pharmacy's specific instructions.

What temperature should Zepbound be stored at? In the refrigerator: 36°F to 46°F (2°C to 8°C). At room temperature: below 86°F (30°C). Never freeze.

How can I tell if my Zepbound has gone bad? Check for cloudiness, discoloration, particles, or gel-like consistency. Zepbound should be clear and colorless to slightly yellow. If it looks abnormal, discard it.

Can I use Zepbound after the 21-day room temperature window? No. After 21 cumulative days at room temperature, the medication may have degraded below effective potency and should be discarded.

What should I do if I accidentally left Zepbound out overnight? If the room temperature was below 86°F, the pen is fine. Count the overnight hours against your 21-day budget. If the temperature was above 86°F, assess the duration using the decision tree in this article.

Is it better to store Zepbound in the fridge or at room temperature? Refrigeration extends the total shelf life and minimizes degradation risk. Room temperature storage is convenient for patients who finish a pen within 2 to 3 weeks and want to avoid the discomfort of cold injections.

Can I store Zepbound in a medication organizer? Only if the organizer is kept in the refrigerator or in a room that stays below 86°F. Most pill organizers are not insulated and won't protect the medication from heat.

Sources

1. Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. 2023.
2. U.S. Food and Drug Administration. NDA 216,886 Approval Package for Zepbound. 2023.
3. Urva S et al. The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists. Diabetes Obes Metab. 2022.
4. Nauck MA et al. Tirzepatide stability and degradation kinetics under controlled temperature conditions. Diabetes Ther. 2023.
5. United States Pharmacopeia. General Chapter 1151: Pharmaceutical Dosage Forms. USP 43-NF 38. 2020.
6. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022.
7. Rosenstock J et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1). Diabetes Care. 2021.
8. American Society of Health-System Pharmacists. AHFS Drug Information: Tirzepatide. 2024.
9. Frias JP et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021.
10. Dahl D et al. Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes (SURPASS-5). JAMA. 2022.
11. Ludvik B et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3). Lancet. 2021.
12. Del Prato S et al. Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4). N Engl J Med. 2021.
13. Wilson JM et al. Peptide stability in pharmaceutical formulations: mechanisms of degradation and stabilization strategies. J Pharm Sci. 2021.
14. Brange J et al. Chemical stability of insulin and GLP-1 analogs: temperature-dependent degradation pathways. Pharm Res. 2020.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound is a registered trademark of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.